Header Logo

Connection

JACOB MANDEL to Retrospective Studies

Back to Details
This is a "connection" page, showing publications JACOB MANDEL has written about Retrospective Studies.
JACOB MANDEL
Connection Strength
0.279
Retrospective Studies
  1. IDH mutation status and the development of venous thromboembolism in astrocytoma patients. J Neurol Sci. 2021 Aug 15; 427:117538.
    View in: PubMed
    Score: 0.050
  2. Effect of health disparities on overall survival of patients with glioblastoma. J Neurooncol. 2019 Apr; 142(2):365-374.
    View in: PubMed
    Score: 0.042
  3. Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma. J Neurooncol. 2016 08; 129(1):147-54.
    View in: PubMed
    Score: 0.035
  4. Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution. J Neurooncol. 2014 Dec; 120(3):597-605.
    View in: PubMed
    Score: 0.031
  5. Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors. J Neurooncol. 2024 Apr; 167(2):349-359.
    View in: PubMed
    Score: 0.015
  6. Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis. Oncologist. 2023 04 06; 28(4):327-332.
    View in: PubMed
    Score: 0.014
  7. Racial and Socioeconomic Disparities in Patients With Meningioma: A Retrospective Cohort Study. Neurosurgery. 2022 01 01; 90(1):114-123.
    View in: PubMed
    Score: 0.013
  8. Height in adolescence as a risk factor for glioma subtypes: a nationwide retrospective cohort study of 2.2 million subjects. Neuro Oncol. 2021 08 02; 23(8):1383-1392.
    View in: PubMed
    Score: 0.013
  9. Multicentric non-enhancing lesions in glioblastoma: A retrospective study. J Clin Neurosci. 2021 Mar; 85:20-26.
    View in: PubMed
    Score: 0.012
  10. Treatment strategies for glioblastoma in older patients: age is just a number. J Neurooncol. 2019 Nov; 145(2):357-364.
    View in: PubMed
    Score: 0.011
  11. Neurologic complications of immune checkpoint inhibitors. J Neurooncol. 2018 May; 137(3):601-609.
    View in: PubMed
    Score: 0.010
  12. Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients. J Neurooncol. 2017 Oct; 135(1):75-81.
    View in: PubMed
    Score: 0.009
  13. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics. J Neurooncol. 2015 Nov; 125(2):401-10.
    View in: PubMed
    Score: 0.008
  14. Wound healing complications in brain tumor patients on Bevacizumab. J Neurooncol. 2015 Sep; 124(3):501-6.
    View in: PubMed
    Score: 0.008
  15. Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma. J Neurooncol. 2014 Aug; 119(1):135-40.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.